Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia

Background: Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been associated with these vaccines. Thus, we aimed to evaluate short-term post-vaccination side effects. Methods: Cross-section...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccines (Basel) Ročník 9; číslo 6; s. 674
Hlavní autoři: Alhazmi, Abdulaziz, Alamer, Edrous, Daws, Dalia, Hakami, Mashael, Darraj, Majid, Abdelwahab, Siddig, Maghfuri, Amani, Algaissi, Abdullah
Médium: Journal Article
Jazyk:angličtina
Vydáno: Basel MDPI AG 18.06.2021
MDPI
Témata:
Adenoviruses
Age
Chronic illnesses
Clinical trials
Coronaviruses
COVID-19
COVID-19 vaccines
Disease prevention
Drug dosages
Fatigue
FDA approval
Fever
Infections
mRNA vaccines
Pain
Pandemics
Population
Questionnaires
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Side effects
Social networks
vaccine
Vaccines
Saudi Arabia
United States > US
ISSN:2076-393X, 2076-393X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background: Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been associated with these vaccines. Thus, we aimed to evaluate short-term post-vaccination side effects. Methods: Cross-sectional, retrospective study using an online questionnaire was conducted among COVID-19 vaccines recipients in Saudi Arabia. General and demographic data were collected, and vaccine-associated side effects after receiving at least one dose of each vaccine were evaluated. Results: Our final sample consisted of 515 participants with a median age of 26 years. Most of the study participants were female (57%). Nearly 13% of the study subjects have reported previous infections with SARS-CoV-2. Oxford-AstraZeneca and Pfizer-BioNTech vaccines have been received by 75% and 25% of the study participants, respectively. Side effects associated with COVID-19 vaccines have been reported by 60% of the study subjects, and most of them reported fatigue (90%), pain at the site of the injections (85%). Conclusion: Side effects that are reported post Oxford-AstraZeneca and Pfizer-BioNTech vaccines among our study participants are not different from those that were reported in the clinical trials, indicating safe profiles for both vaccines. Further studies are needed to evaluate the effectiveness of the current vaccines in protection against SARS-CoV-2 reinfections.
AbstractList Background: Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been associated with these vaccines. Thus, we aimed to evaluate short-term post-vaccination side effects. Methods: Cross-sectional, retrospective study using an online questionnaire was conducted among COVID-19 vaccines recipients in Saudi Arabia. General and demographic data were collected, and vaccine-associated side effects after receiving at least one dose of each vaccine were evaluated. Results: Our final sample consisted of 515 participants with a median age of 26 years. Most of the study participants were female (57%). Nearly 13% of the study subjects have reported previous infections with SARS-CoV-2. Oxford-AstraZeneca and Pfizer-BioNTech vaccines have been received by 75% and 25% of the study participants, respectively. Side effects associated with COVID-19 vaccines have been reported by 60% of the study subjects, and most of them reported fatigue (90%), pain at the site of the injections (85%). Conclusion: Side effects that are reported post Oxford-AstraZeneca and Pfizer-BioNTech vaccines among our study participants are not different from those that were reported in the clinical trials, indicating safe profiles for both vaccines. Further studies are needed to evaluate the effectiveness of the current vaccines in protection against SARS-CoV-2 reinfections.
Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been associated with these vaccines. Thus, we aimed to evaluate short-term post-vaccination side effects.BACKGROUNDPfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been associated with these vaccines. Thus, we aimed to evaluate short-term post-vaccination side effects.Cross-sectional, retrospective study using an online questionnaire was conducted among COVID-19 vaccines recipients in Saudi Arabia. General and demographic data were collected, and vaccine-associated side effects after receiving at least one dose of each vaccine were evaluated.METHODSCross-sectional, retrospective study using an online questionnaire was conducted among COVID-19 vaccines recipients in Saudi Arabia. General and demographic data were collected, and vaccine-associated side effects after receiving at least one dose of each vaccine were evaluated.Our final sample consisted of 515 participants with a median age of 26 years. Most of the study participants were female (57%). Nearly 13% of the study subjects have reported previous infections with SARS-CoV-2. Oxford-AstraZeneca and Pfizer-BioNTech vaccines have been received by 75% and 25% of the study participants, respectively. Side effects associated with COVID-19 vaccines have been reported by 60% of the study subjects, and most of them reported fatigue (90%), pain at the site of the injections (85%).RESULTSOur final sample consisted of 515 participants with a median age of 26 years. Most of the study participants were female (57%). Nearly 13% of the study subjects have reported previous infections with SARS-CoV-2. Oxford-AstraZeneca and Pfizer-BioNTech vaccines have been received by 75% and 25% of the study participants, respectively. Side effects associated with COVID-19 vaccines have been reported by 60% of the study subjects, and most of them reported fatigue (90%), pain at the site of the injections (85%).Side effects that are reported post Oxford-AstraZeneca and Pfizer-BioNTech vaccines among our study participants are not different from those that were reported in the clinical trials, indicating safe profiles for both vaccines. Further studies are needed to evaluate the effectiveness of the current vaccines in protection against SARS-CoV-2 reinfections.CONCLUSIONSide effects that are reported post Oxford-AstraZeneca and Pfizer-BioNTech vaccines among our study participants are not different from those that were reported in the clinical trials, indicating safe profiles for both vaccines. Further studies are needed to evaluate the effectiveness of the current vaccines in protection against SARS-CoV-2 reinfections.
Author Abdelwahab, Siddig
Maghfuri, Amani
Alhazmi, Abdulaziz
Hakami, Mashael
Algaissi, Abdullah
Daws, Dalia
Alamer, Edrous
Darraj, Majid
AuthorAffiliation 4 Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia
1 Department of Microbiology and Parasitology, College of Medicine, Jazan University, Jazan 45142, Saudi Arabia; abalhazmi@jazanu.edu.sa
6 College of Medicine, Jazan University, Jazan 45142, Saudi Arabia; Amanimgf@gmail.com
5 Department of Medicine, College of Medicine, Jazan University, Jazan 45142, Saudi Arabia; mdarraj@jazanu.edu.sa
2 Jazan University Hospital, Jazan University, Jazan 45142, Saudi Arabia; ddous@jazanu.edu.sa (D.D.); mashael@jazanu.edu.sa (M.H.)
3 Medical Research Center, Jazan University, Jazan 45142, Saudi Arabia; ealamer@jazanu.edu.sa (E.A.); sadiqa@jazanu.edu.sa (S.A.)
AuthorAffiliation_xml – name: 4 Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia
– name: 1 Department of Microbiology and Parasitology, College of Medicine, Jazan University, Jazan 45142, Saudi Arabia; abalhazmi@jazanu.edu.sa
– name: 2 Jazan University Hospital, Jazan University, Jazan 45142, Saudi Arabia; ddous@jazanu.edu.sa (D.D.); mashael@jazanu.edu.sa (M.H.)
– name: 6 College of Medicine, Jazan University, Jazan 45142, Saudi Arabia; Amanimgf@gmail.com
– name: 5 Department of Medicine, College of Medicine, Jazan University, Jazan 45142, Saudi Arabia; mdarraj@jazanu.edu.sa
– name: 3 Medical Research Center, Jazan University, Jazan 45142, Saudi Arabia; ealamer@jazanu.edu.sa (E.A.); sadiqa@jazanu.edu.sa (S.A.)
Author_xml – sequence: 1
  givenname: Abdulaziz
  orcidid: 0000-0002-4260-6540
  surname: Alhazmi
  fullname: Alhazmi, Abdulaziz
– sequence: 2
  givenname: Edrous
  orcidid: 0000-0002-9700-1610
  surname: Alamer
  fullname: Alamer, Edrous
– sequence: 3
  givenname: Dalia
  orcidid: 0000-0001-9649-1614
  surname: Daws
  fullname: Daws, Dalia
– sequence: 4
  givenname: Mashael
  orcidid: 0000-0001-7037-9333
  surname: Hakami
  fullname: Hakami, Mashael
– sequence: 5
  givenname: Majid
  surname: Darraj
  fullname: Darraj, Majid
– sequence: 6
  givenname: Siddig
  orcidid: 0000-0002-6145-4466
  surname: Abdelwahab
  fullname: Abdelwahab, Siddig
– sequence: 7
  givenname: Amani
  surname: Maghfuri
  fullname: Maghfuri, Amani
– sequence: 8
  givenname: Abdullah
  orcidid: 0000-0002-5386-406X
  surname: Algaissi
  fullname: Algaissi, Abdullah
BookMark eNp1kUtrGzEUhUVJaNIk624F3XQzjTR6zGhTMK6TGgxZ5EF34o4eicx4lEozLv33VWJTGkO1kbj3nE-Xez6goyEODqGPlHxhTJHLLRgTBpcVkUQ2_B06rUkjK6bYj6N_3ifoIuc1KUdR1srmPTphvHSZ4qdotdhCP8EY4oCjx7fBOrzw3pkx41nO0QQYncW_wviE5zcPy28VVfhh_zEOA76FyQY8S9AFOEfHHvrsLvb3Gbq_WtzNv1erm-vlfLaqDJd8rKAmlFArm7o2ngrVMSuYNZ0SHQBpBWkEI5wS57wEDp0XrBRa5R1IK5RjZ2i549oIa_2cwgbSbx0h6NdCTI8a0hhM7zSRpmk7UnOiPDfKtsBEZyy1IISUzhTW1x3reeo2zho3jAn6N9C3nSE86ce41W3NRFlpAXzeA1L8Obk86k3IxvU9DC5OWdeCt5y0bSOL9NOBdB2nNJRVvai4YkpRXlSXO5VJMefk_N9hKNEvweuD4ItDHDhMGF8zLROH_r--P84bs3U
CitedBy_id crossref_primary_10_1111_jocd_15261
crossref_primary_10_3390_vaccines9111297
crossref_primary_10_1007_s11356_023_25527_2
crossref_primary_10_3390_vaccines10071047
crossref_primary_10_3389_fmed_2021_760047
crossref_primary_10_1002_hsr2_1012
crossref_primary_10_3390_vaccines10030466
crossref_primary_10_51847_1LBLzTVHfO
crossref_primary_10_1186_s12905_023_02331_1
crossref_primary_10_1186_s12879_023_08462_y
crossref_primary_10_3390_healthcare11182517
crossref_primary_10_3390_vaccines11030558
crossref_primary_10_1016_j_cegh_2022_101175
crossref_primary_10_1177_23779608221103208
crossref_primary_10_1016_j_ejr_2022_12_003
crossref_primary_10_1016_j_prp_2023_154497
crossref_primary_10_3389_fpubh_2022_834744
crossref_primary_10_7759_cureus_29306
crossref_primary_10_1371_journal_pone_0274526
crossref_primary_10_1016_j_mvr_2023_104500
crossref_primary_10_1186_s10194_022_01400_4
crossref_primary_10_3390_vaccines9101096
crossref_primary_10_1097_MD_0000000000041656
crossref_primary_10_3390_vaccines10060846
crossref_primary_10_1016_j_aanat_2025_152662
crossref_primary_10_1371_journal_pone_0278334
crossref_primary_10_12688_f1000research_134171_2
crossref_primary_10_1136_bmjopen_2023_072650
crossref_primary_10_3390_vaccines10010109
crossref_primary_10_12688_f1000research_134171_1
crossref_primary_10_52711_2231_5659_2023_00034
crossref_primary_10_3390_vaccines9121437
crossref_primary_10_1007_s40264_021_01131_6
crossref_primary_10_1177_03946320241239202
crossref_primary_10_1080_21645515_2022_2104059
crossref_primary_10_1016_j_jsps_2024_102126
crossref_primary_10_3390_vaccines10030366
crossref_primary_10_1109_ACCESS_2024_3389655
crossref_primary_10_3390_vaccines10030401
crossref_primary_10_4103_picr_picr_64_23
crossref_primary_10_1007_s40267_022_00893_y
crossref_primary_10_3390_vaccines11020316
crossref_primary_10_1108_AGJSR_04_2023_0144
crossref_primary_10_3390_ph14101049
crossref_primary_10_1080_07853890_2023_2241351
crossref_primary_10_1063_5_0284293
crossref_primary_10_12688_f1000research_110270_2
crossref_primary_10_12688_f1000research_110270_1
crossref_primary_10_2147_POR_S381836
crossref_primary_10_1038_s41598_022_23471_8
crossref_primary_10_3390_vaccines9101158
crossref_primary_10_3390_v15071500
crossref_primary_10_4103_ijoem_ijoem_275_22
crossref_primary_10_1002_edm2_70004
crossref_primary_10_22207_JPAM_17_2_21
crossref_primary_10_3390_vaccines10122089
crossref_primary_10_1371_journal_pone_0275425
crossref_primary_10_3389_fpubh_2022_896343
crossref_primary_10_3390_vaccines11020266
crossref_primary_10_7759_cureus_71170
crossref_primary_10_7759_cureus_23526
crossref_primary_10_2147_IJGM_S379204
crossref_primary_10_3390_vaccines10020223
crossref_primary_10_2147_IDR_S409200
crossref_primary_10_3390_vaccines10101771
crossref_primary_10_3390_vaccines11020257
crossref_primary_10_3390_vaccines9111369
crossref_primary_10_5817_CSF2023_1_45
crossref_primary_10_2147_JMDH_S331140
crossref_primary_10_3390_vaccines10060924
crossref_primary_10_3390_vaccines9070757
crossref_primary_10_3390_biology10080752
crossref_primary_10_3390_vaccines10020186
crossref_primary_10_4103_abhs_abhs_115_24
crossref_primary_10_1186_s12879_022_07905_2
crossref_primary_10_1016_j_ijid_2022_03_007
crossref_primary_10_1038_s41598_024_75833_z
crossref_primary_10_7759_cureus_51583
crossref_primary_10_7759_cureus_58892
crossref_primary_10_2147_IDR_S374265
crossref_primary_10_2147_PPA_S330689
crossref_primary_10_3390_ph14090873
crossref_primary_10_3389_fphar_2025_1561410
crossref_primary_10_3390_vaccines10060977
crossref_primary_10_1186_s40249_021_00915_3
crossref_primary_10_1016_j_lfs_2024_122535
crossref_primary_10_1016_j_sciaf_2024_e02399
crossref_primary_10_3390_jcm10225338
crossref_primary_10_12688_f1000research_145862_1
crossref_primary_10_3390_vaccines11020231
crossref_primary_10_1186_s42269_023_01041_w
crossref_primary_10_7759_cureus_40460
crossref_primary_10_3390_vaccines10030434
crossref_primary_10_1080_14760584_2022_2116008
crossref_primary_10_7759_cureus_31359
crossref_primary_10_1016_j_vaccine_2022_10_009
crossref_primary_10_21926_obm_genet_2502295
Cites_doi 10.3390/v13030418
10.3390/vaccines9030226
10.1016/S0140-6736(20)32466-1
10.3390/vaccines9030274
10.1016/S0140-6736(11)60678-8
10.4161/hv.24657
10.3390/vaccines9050515
10.1016/S1473-3099(21)00224-3
10.1016/S0140-6736(20)32661-1
10.1002/rmv.2183
10.2147/IJGM.S310497
10.1038/d41586-020-03441-8
10.1016/j.jiph.2020.04.016
10.1056/NEJMoa2034577
10.1007/s12038-020-00114-6
10.7326/M20-7357
10.3390/v13010054
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
3V.
7T7
7XB
8FD
8FE
8FH
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
COVID
DWQXO
FR3
GNUQQ
GUQSH
HCIFZ
LK8
M2O
M7P
MBDVC
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/vaccines9060674
DatabaseName CrossRef
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Engineering Research Database
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
ProQuest Biological Science Collection
Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Coronavirus Research Database
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef


MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2076-393X
ExternalDocumentID oai_doaj_org_article_06c78b02409f4c9d8a35bcd1da5566ec
PMC8235009
10_3390_vaccines9060674
GeographicLocations Saudi Arabia
United States--US
GeographicLocations_xml – name: Saudi Arabia
– name: United States--US
GroupedDBID 53G
5VS
8FE
8FH
8G5
AADQD
AAHBH
AAYXX
ABUWG
ADBBV
AEUYN
AFFHD
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
CITATION
DIK
DWQXO
GNUQQ
GROUPED_DOAJ
GUQSH
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQGLB
PQQKQ
PROAC
RNS
RPM
3V.
7T7
7XB
8FD
8FK
C1K
COVID
FR3
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c464t-a20101d6722cf159b3d53dcb95baa08507530410eef6a4abf5353089fea6d59e3
IEDL.DBID DOA
ISICitedReferencesCount 114
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000666960800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2076-393X
IngestDate Fri Oct 03 12:26:45 EDT 2025
Tue Nov 04 01:57:58 EST 2025
Fri Sep 05 08:04:09 EDT 2025
Fri Jul 25 10:45:20 EDT 2025
Tue Nov 18 22:39:03 EST 2025
Sat Nov 29 07:15:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c464t-a20101d6722cf159b3d53dcb95baa08507530410eef6a4abf5353089fea6d59e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9649-1614
0000-0002-5386-406X
0000-0002-6145-4466
0000-0001-7037-9333
0000-0002-4260-6540
0000-0002-9700-1610
OpenAccessLink https://doaj.org/article/06c78b02409f4c9d8a35bcd1da5566ec
PMID 34207394
PQID 2544939914
PQPubID 2032320
ParticipantIDs doaj_primary_oai_doaj_org_article_06c78b02409f4c9d8a35bcd1da5566ec
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8235009
proquest_miscellaneous_2548408876
proquest_journals_2544939914
crossref_primary_10_3390_vaccines9060674
crossref_citationtrail_10_3390_vaccines9060674
PublicationCentury 2000
PublicationDate 20210618
PublicationDateYYYYMMDD 2021-06-18
PublicationDate_xml – month: 6
  year: 2021
  text: 20210618
  day: 18
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Vaccines (Basel)
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Caplan (ref_5) 2021; 174
Ledford (ref_6) 2020; 588
ref_14
Ramasamy (ref_19) 2021; 396
Harakeh (ref_18) 2021; 14
ref_11
Laberge (ref_13) 2013; 9
ref_21
ref_20
Cucinotta (ref_1) 2020; 91
Arashkia (ref_3) 2020; 31
Voysey (ref_10) 2021; 397
Larson (ref_12) 2011; 378
Sreepadmanabh (ref_4) 2020; 45
ref_17
ref_16
ref_15
ref_8
Polack (ref_9) 2020; 383
ref_7
Algaissi (ref_2) 2020; 13
References_xml – ident: ref_8
– ident: ref_20
  doi: 10.3390/v13030418
– ident: ref_16
  doi: 10.3390/vaccines9030226
– volume: 396
  start-page: 1979
  year: 2021
  ident: ref_19
  article-title: Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): A single-blind, randomised, controlled, phase 2/3 trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)32466-1
– ident: ref_11
– ident: ref_15
  doi: 10.3390/vaccines9030274
– volume: 91
  start-page: 157
  year: 2020
  ident: ref_1
  article-title: WHO declares COVID-19 a pandemic
  publication-title: Acta Biomed.
– volume: 378
  start-page: 526
  year: 2011
  ident: ref_12
  article-title: Addressing the vaccine confidence gap
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60678-8
– volume: 9
  start-page: 1763
  year: 2013
  ident: ref_13
  article-title: Vaccine hesitancy: An overview: An overview
  publication-title: Hum. Vaccin. Immunother.
  doi: 10.4161/hv.24657
– ident: ref_14
  doi: 10.3390/vaccines9050515
– ident: ref_17
  doi: 10.1016/S1473-3099(21)00224-3
– volume: 397
  start-page: 99
  year: 2021
  ident: ref_10
  article-title: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)32661-1
– volume: 31
  start-page: e2183
  year: 2020
  ident: ref_3
  article-title: Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects
  publication-title: Rev. Med. Virol.
  doi: 10.1002/rmv.2183
– volume: 14
  start-page: 1389
  year: 2021
  ident: ref_18
  article-title: Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: A retrospective cross-sectional study
  publication-title: Int. J. Gen. Med.
  doi: 10.2147/IJGM.S310497
– volume: 588
  start-page: 205
  year: 2020
  ident: ref_6
  article-title: The UK has approved a COVID vaccine—Here’s what scientists now want to know
  publication-title: Nature
  doi: 10.1038/d41586-020-03441-8
– volume: 13
  start-page: 834
  year: 2020
  ident: ref_2
  article-title: Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
  publication-title: J. Infect. Public Health
  doi: 10.1016/j.jiph.2020.04.016
– volume: 383
  start-page: 2603
  year: 2020
  ident: ref_9
  article-title: Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2034577
– volume: 45
  start-page: 148
  year: 2020
  ident: ref_4
  article-title: COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development
  publication-title: J. Biosci.
  doi: 10.1007/s12038-020-00114-6
– ident: ref_21
– volume: 174
  start-page: 258
  year: 2021
  ident: ref_5
  article-title: Ethical and scientific considerations regarding the early approval and deployment of a COVID-19 vaccine
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M20-7357
– ident: ref_7
  doi: 10.3390/v13010054
SSID ssj0000913867
Score 2.51862
Snippet Background: Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to combat COVID-19 pandemic. During clinical trials, mild to moderate side...
Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 674
SubjectTerms Adenoviruses
Age
Chronic illnesses
Clinical trials
Coronaviruses
COVID-19
COVID-19 vaccines
Disease prevention
Drug dosages
Fatigue
FDA approval
Fever
Infections
mRNA vaccines
Pain
Pandemics
Population
Questionnaires
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Side effects
Social networks
vaccine
Vaccines
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgy4ELlJcaKJWRUMWhoXnYsX1CtN0KpGpZ0VL1FvkJkVBSNruV-u_xJN5sgwQXrrYjO_o843nY3yD01qWOcU1d7DUdpBk19XpQsTgTqdO8KKwT3UPhMzab8asrMQ8BtzZcq1zrxE5Rm0ZDjPwQqLSEP01T8uH6VwxVoyC7Gkpo3EdbwFRGJmjraDqbfx2iLMB6yQvWc_rk3r8_vJEaMtatSLzpzsjoOOpY-0em5vii5J2T5_Tx_655Gz0KNif-2G-SJ-ierZ-i_XlPWn17gC82b7DaA7yP5xs669tn6Gw6EILjxuHzyljccx63eA2uNRgCuvj4y-XnkzgV-DL8P65qfC5XpvKzS1XJ5-jb6fTi-FMcajDEmhRkGUvIlqemYFmmnTd9VG5obrQSVEkJdHfe3UlImljrCkmkcjT3DVw4KwtDhc1foEnd1HYHYUapIonUxqiM8ExLcMuFZIlQ3sgjIkLv11CUOhCUQ52Mn6V3VAC78g_sIvRu-OC65-b4-9AjwHYYBqTaXUOz-F4GGS2TQjOugPRNOKKF4TKnSpvUSOqNXqsjtLuGuQyS3pYbjCP0Zuj2MgqJF1nbZtWN8X60V-dFhNhoR40WNO6pqx8d2zfPcur38ct_T_4KPczgtg1UVeK7aLJcrOxr9EDfLKt2sRfE4je-pBoJ
  priority: 102
  providerName: ProQuest
Title Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia
URI https://www.proquest.com/docview/2544939914
https://www.proquest.com/docview/2548408876
https://pubmed.ncbi.nlm.nih.gov/PMC8235009
https://doaj.org/article/06c78b02409f4c9d8a35bcd1da5566ec
Volume 9
WOSCitedRecordID wos000666960800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2076-393X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000913867
  issn: 2076-393X
  databaseCode: DOA
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2076-393X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000913867
  issn: 2076-393X
  databaseCode: M~E
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2076-393X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000913867
  issn: 2076-393X
  databaseCode: M7P
  dateStart: 20130301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2076-393X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000913867
  issn: 2076-393X
  databaseCode: BENPR
  dateStart: 20130301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2076-393X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000913867
  issn: 2076-393X
  databaseCode: PIMPY
  dateStart: 20130301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 2076-393X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000913867
  issn: 2076-393X
  databaseCode: M2O
  dateStart: 20130301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagcOCCykssLSsjoYpDQ_OwY_tIy1ZUarcRLdVyivxUI6EsanYr9cJvZybJbjdIiAsXH2xHdsbjyTcZ-xtC3ockCGl5iMDSYZjRcrCDRkSpSoKVee6Dai8Kn4rpVM5mqthI9YVnwjp64E5wB3FuhTTIxKUCs8pJnXFjXeI0ByTiLVpfQD0bzlRrg1WSyVx0XD4Z-PUHt9pipLpRMUB2wQafoZatfwAxhwckN744x9vkaQ8V6aduis_IA18_J3tFxzV9t08v769ONft0jxb3LNR3L8jpZM3jTeeBXlTO046quKGrNfGO4n9YenR-dfI5ShS96qdPq5pe6KWrYHRtKv2SfDueXB59ifrUCZFlOVtEGoPcictFmtoAiMVkjmfOGsWN1shSB15KzJLY-5Brpk3gGVRIFbzOHVc-e0W26nntXxMqODcs1tY5kzKZWo3etNIiVgawGVMj8nElydL2vOKY3uJHCf4Fir78Q_Qj8mH9wM-OUuPvXQ9xadbdkAu7rQANKXsNKf-lISOyu1rYst-gTYnMbArAWQJjvFs3w9bCeImu_XzZ9gH3F6xwPiJioBCDCQ1b6uq6JemWacZBDd_8jzfYIU9SPEqDKZPkLtla3Cz9W_LY3i6q5mZMHoqZHJNHh5Np8XXc7gMoz9JzLEWB5a8JtBcnZ8X3384aEkg
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQYILb0SggJGg4tDQPOzEPiAEfairLstKXaregp8QCSVls1u0f4rfiCevJUhw64Gr7cSJ_XlmPGN_g9ALG9qUKWp9J-kgzKiok4My9SMeWsWSxFheXxQep5MJOzvj0w30s7sLA8cqO5lYC2pdKvCR7wKVFnfaNCRvz7_7kDUKoqtdCo0GFsdm9cNt2ao3o303vy-j6PBgtnfkt1kFfEUSsvAFxH9DnaRRpKxT5jLWNNZKciqFAAI3Z8AHJAyMsYkgQloauwLGrRGJptzE7r1X0FVnRkSsPio47X06wLHJkrRhEIpjHuxeCAXx8YoHbqOQkoHyq3MEDAzb4bHM3_Tc4a3_bYRuo5utRY3fNUvgDtowxV20PW0ouVc7eLa-YVbt4G08XZN1r-6h8UFPd45Li09ybXDD6FzhDrpGY3BX472Pp6N9P-T4tB1vnBf4RCx17noXMhf30adL-dMHaLMoC_MQ4ZRSSQKhtJYRYZES4HTgIg24dCYs4R563U19plr6dcgC8i1z2zDASvYHVjz0qn_gvGEe-XvT94ClvhlQhtcF5fxL1kqgLEhUyiRQ2nFLFNdMxFQqHWpBnUlvlIe2OlhlrRyrsjWmPPS8r3YSCMJKojDlsm7DCCirxEPpAMGDDxrWFPnXmsucRTF16-bRvzt_hq4fzT6Ms_FocvwY3YjgXBHkj2JbaHMxX5on6Jq6WOTV_Gm9IDH6fNn4_gWpoXUY
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKixAX3ohAASNBxaFh87Bj-4AQ7e6KVVfLipaqt9RPiISSstkt2r_Gr8POawkS3HrgGjtx4nyeGc-MvwHgpQkNoRIb30o6F2aU2MpBQfyIhUbSJNGGVQeFp2Q2o2dnbL4FfrZnYVxaZSsTK0GtCul85ANHpcWsNg3RwDRpEfPh-N3Fd99VkHKR1racRg2RI73-Ybdv5dvJ0P7rV1E0Hp0cfvCbCgO-RAla-tzFgkOVkCiSxip2ESscKykYFpw7MjdrzAcoDLQ2CUdcGBzbC5QZzROFmY7tc6-BHWKNDLu6dg5Gs_mnzsPjGDdpQmo-oThmweCSSxctL1lgtw0E9VRhVTGgZ-b2kzR_03rj2__zfN0BtxpbG76vF8ddsKXze2BvXpN1r_fhyebsWbkP9-B8Q-O9vg-mo44IHRYGHmdKw5rruYQtqLWCzpENDz-eToZ-yOBpM_cwy-ExX6nMjs5Fxh-Az1fypQ_Bdl7k-hGABGOBAi6VEhGikeTOHcE4CZiwxi1iHnjTwiCVDTG7qw_yLbUbNIeb9A_ceOB1d8NFzUny964HDlddN0cmXl0oFl_SRjalQSIJFY7sjhkkmaI8xkKqUHFsjX0tPbDbQixtJFyZbvDlgRdds5VNLuDEc12sqj4UOTWWeID00Nx7oX5Lnn2tWM5pFGO7hh7_e_Dn4IaFdTqdzI6egJuRSzhyhaXoLtheLlb6KbguL5dZuXjWrE4Izq8a4L8ATXZ_KA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+Side+Effects+Associated+with+COVID-19+Vaccines+in+Saudi+Arabia&rft.jtitle=Vaccines+%28Basel%29&rft.au=Alhazmi%2C+Abdulaziz&rft.au=Alamer%2C+Edrous&rft.au=Daws%2C+Dalia&rft.au=Hakami%2C+Mashael&rft.date=2021-06-18&rft.pub=MDPI&rft.eissn=2076-393X&rft.volume=9&rft.issue=6&rft_id=info:doi/10.3390%2Fvaccines9060674&rft_id=info%3Apmid%2F34207394&rft.externalDocID=PMC8235009
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon